JG
BPTH

Jefferies Group’s Bio-Path Holdings Inc BPTH Stock Holding History

Jefferies Group’s Portfolio BPTH Stock Details BPTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-6
Closed -$64K – 2513
2016
Q1 		$64K Buy
+6
New +$38.9K ﹤0.01% 2019

Other funds holding BPTH

UOTTAIMCU
University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $687M AUM 21.33% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RCA
Rowland Carmichael Advisors Scottsdale, Arizona $316M AUM 18.07% 1-Year Est. Return

Jefferies Group's BPTH Position: Q2 2016 in Review

Jefferies Group sold out of Bio-Path Holdings Inc (BPTH) in Q2 2016, closing a stake of 6 shares — an estimated $64K sold.

Jefferies Group first reported a position in BPTH in Q1 2016 and held it in 1 quarter. The position peaked at $64K in Q1 2016. 46 funds tracked by Wall St. Rank hold BPTH as of Q2 2016.

  • Jefferies Group reported no remaining Bio-Path Holdings Inc position as of Q2 2016 after selling out during the quarter.
  • Jefferies Group sold 6 Bio-Path Holdings Inc shares in Q2 2016, an estimated $64K.
  • Jefferies Group first reported a position in Bio-Path Holdings Inc in Q1 2016 and held it in 1 quarter.
  • Jefferies Group's Bio-Path Holdings Inc position peaked at $64K in Q1 2016.
  • 46 funds tracked by Wall St. Rank held Bio-Path Holdings Inc as of Q2 2016.

Based on Jefferies Group's 13F filing for Q2 2016, filed 12 Aug 2016.